Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months

Winterhalter S,Annabelle Eckert,Gerrit Alexander Vom Brocke,Alice Schneider,Dominika Pohlmann,Daniel Pilger,Antonia M. Joussen,Matus Rehak,Ulrike Grittner

Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months

2018

Winterhalter S
Annabelle Eckert
Gerrit Alexander Vom Brocke
Alice Schneider
Dominika Pohlmann
Daniel Pilger
Antonia M. Joussen
Matus Rehak
Ulrike Grittner

Purpose To evaluate the therapeutic outcome for dexamethasone implant (DEX) or intravitreal ranibizumab (IVR) injections over 6 months in patients with macular edema due to branch or central retinal vein occlusion (BRVO, CRVO), in a real-life setting.

Keywords:

Ranibizumab
Dexamethasone
Implant
Branch retinal vein occlusion
Internal medicine
Cardiology
Macular edema
Medicine
Central retinal vein occlusion
Diabetes mellitus
Ophthalmology
in patient
Anatomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations